The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I noted the Yorkshire cancer research which is one CIZ major share holders is also supporting a trial for lung cancer screening using CT scan. The main Universities Sheffield, Leeds, York are involved (also share holders in CIZ). Could use the same cohort of patients for CIZ biomarker trial?
https://yorkshirecancerresearch.org.uk/news/lung-screening-trial-checks-5600-people
channels ares till intact, it will be ok (with the right news)
Good morning, that is how i see the chart over the next few weeks, compare the pattern with April 20 and July 18, we ll see:
https://invst.ly/uv1pk
Website, looks nice
https://cizzlebiotechnology.com
Since we launched more or less at the same sp before suspension after consolidation, I pulled out the old bou chart, still works-:) old figures x 500, noticed the following:
-Before suspension. the sp was on breakout mode at 0.024 (12)
-the SP retested the BO line and the strong support (yearly) line at 9p and bounced.
- 9p is the equivalent of 0.018 (old money) which was also the OO price when it was a cash shell.
-the live sell/buy before close yesterday was 9.25 vs 9.39, a very tight spread and not as shown on LSE.
-I could sell all shares in one of my accounts (88000) without any problem (have not sold any) in the afternoon, plenty of buyers out there.
-So, basically for the LTHs, hold to your share, (never sell at support, abc of trading), if I was a new buyer i would be scooping the shares at this level, only way is up, chart attached for guidance only:
https://invst.ly/utj7u